Organ‐Specific Autoimmunity: A 1986 Overview

Immunological Reviews

Volumn 94, Issue 1, 1986, Pages 137-169

  Bottazzo, Gian Franco ^a   Todd, Ian ^a   Mirakian, Rita ^a   Belfiore, Antonio ^a   Pujol‐Borrell, Ricardo ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; AUTOANTIBODY; CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 2; HORMONE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; ENDOCRINE SYSTEM; ETIOLOGY; HLA SYSTEM; HUMAN; IMMUNOPATHOLOGY; JOINT; LYMPHATIC SYSTEM; PRIORITY JOURNAL; REVIEW; ANIMAL; ANTIBODY SPECIFICITY; B LYMPHOCYTE; ENDOCRINE GLAND; EPITHELIUM; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE; SEX DIFFERENCE;

ANIMAL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DIABETES MELLITUS, INSULIN-DEPENDENT; ENDOCRINE GLANDS; EPITHELIUM; HISTOCOMPATIBILITY ANTIGENS CLASS II; HORMONES; HUMAN; INTESTINES; RECEPTORS, CELL SURFACE; SEX FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0022931249     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1986.tb01168.x     Document Type: Article

References (163)

1. Effects of platelet‐derived growth factor and epidermal growth factor on antigen induced proliferation of human T‐cell lines
2. The clinical status of patients whose sera have given the abnormal response when assayed for thyrotropin
3. The presence of an abnormal thyroid‐stimulating hormone in the serum of some thyrotoxic patients
4. In situ immune complexes, lymphocytes subpopulations and HLA‐DR positive epithelial cells in Hashimoto thyroiditis
5. Pathogenesis of insulin dependent diabetes: A role for activated T‐ lymphocytes
6. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins
7. Aberrant expression of HLA‐DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis
8. Structural features of the autoantigens involved in thyroid autoimmune disease: the thyroid microsomal/microvillar antigen
9. Further studies of the production by rabbits of thyroid‐stimulating anti‐idiotypic antibodies to TSH
10. Effect of SV‐40 transformation on HLA expression by thyroid follicular cells: a rise of a population of DR positive thyrocytes
11. Demonstration and characterization of anti‐human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions
12. Antibodies to melanocytes in vitiligo
13. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism
14. Islet cell and insulin autoantibodies in association with common viral infections
15. Beta cell damage in diabetic insulitis: are we approaching the solution
16. Death of a Beta Cell: Homicide or Suicide
17. Complement‐fixing islet cell antibodies in Type I diabetes: Possible monitors of active beta‐cell damage
18. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis
19. Polyendocrine Autoimmunity: An extended concept
20. Autoimmune thyroid disease
21. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiences
22. Separate autoantibodies to human pancreatic glucagon and somatostatin cells
23. Autoantibodies to prolactin‐secreting cells of human pituitary
24. Autoimmunity and diabetes: progress, consolidation and controversy
25. Role of aberrant HLA‐DR expression and antigen presentation in induction of endocrine autoimmunity
26. Hypothesis for the genetic contribution to the aetiology of diabetes mellitus
27. Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis
28. Methimazole and insulin autoimmune syndrome
29. Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells IIL Induction of thyroiditis by thyroid‐sensitized T lymphoblasts
30. Detection of thyroid growth immunoglobulins (TGI) by [H] thymidine incorporation in cultured rat thyroid follicles
31. Characterization of the 64,000 MW autoantigen in insulin‐dependent diabetes
32. Multiple Sclerosis and Myasthenia Gravis
33. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases
34. Autoimmune diseases of muscle: myasthemia gravis and myositis
35. Parietal cell surface reactive autoanti‐ body in pernicious anaemia demonstrated by indirect membrane immunofiuorescence
36. Flow microfluodmetric analysis of autoantibody reactions with parietal cell surface membranes in pernicious anaemia
37. Insulin autoantibodies in the pre‐diabetic period: Correlation with islet cell antibodies and development of diabetes
38. Direct and quantitative measurement by immunoprecipitation assay of anti‐thyrotropin receptor antibodies in sera of patients with Graves' disease
39. Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level
40. Role of secretagogue immunoglobulin in gastric acid secretion
41. Clinical observations and hypotheses related to TSH receptors
42. The autoimmune endocrinopathies
43. Thyroid growth‐blocking antibodies in primary myxedema
44. Thyroid growth stimulating and blocking antibodies
45. Evidence for thyroid growth stimulating immunoglobulins in some goitrous thyroid diseases
46. Thyrotrophin stimulation of the rat thyroid cell strain FRTL‐5: a metaphase index assay for the detection of thyroid growth stimulators
47. Detection and properties of TSH‐binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis
48. Development of the gonadotropic resistant ovary syndrome in myasthemia gravis: suggestion of similar autoimmune mechanism
49. The heterogeneity of autoimmune response
50. Studies on thyroid cell surface antigens using cultured human thyroid cells
51. Cyclosporin increases the rate and length of remissions in insulin‐dependent diabetes of recent onset ‐ results of a multicentre double‐blind trail
52. Characterization of antibodies to the insulin receptor: a cause of insulin‐resistant diabetes in man
53. Aberrant expression of HLA‐DR antigens by insulin containing beta cells in recent onset Type I (insulin‐dependent) diabetes mellitus
54. Autonomic abnormalities and autoantibodies to Beta‐adrenergic receptor
55. Islet cell cytoplasmic and cell surface antibodies in diabetes mellitus
56. The induction of immunoglobulins that stimulate thyroid growth, iodide concentration and cause TSH binding in the mouse
57. A cell‐surface molecule involved in organ‐specific homing of lymphocytes
58. Islet cell survival determined by morphology: an immunohistochemical study of the islets of Langerhans in juvenile diabetes mellitus
59. Anterior hypophysitis and Hashimoto's disease in young women
60. Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation
61. In vitro and in vivo reversal of thyroid epithelial polarity: its relevance for autoimmune thyroid disease
62. Aberrant expression of HLA‐DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity
63. Methimazole and insulin autoimmune syndrome with hypoglycaemia
64. Autoimmune human T lymphocytes specific for acetylcholine receptor
65. Rheumatoid arthritis: a disease of T‐lymphocyte/macrophage immunoregulation
66. Intrathyroid HLA‐DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre
67. Autoantibodies to gut secretin cells as markers of peptide deficiency
68. Autoantibodies to parathyroid hormone receptor
69. Possible role of a human adenovirus in the pathogenesis of celiac disease
70. Autoantibodies to insulin receptors in man: Immunological determinants and mechanism of action
71. Insulin as a surface marker on isolated cells from rat pancreatic islets
72. Monoclonal human thyroid cell line GEJ expressing human thyrotropin receptors
73. Persistent expression of la antigen and viral genome in Visna‐Maedi virus‐induced inflammatory cells. Possible role of lentivirus‐induced interferon
74. The thyroid ‘microsomal’ antibody revisited: Its paradoxical binding in vivo to the apical surface of the follicular epithehum
75. Surface reactive antibodies to adrenal cells in Addison's disease
76. Presence of organ‐specific ‘microsomal’ autoantigen on the surface of human thyroid cells in culture: its involvement in complement‐mediated cytotoxicity
77. Evidence in support of a self‐perpetuating HLA‐DR‐dependent delayed‐type cell reaction in rheumatoid arthritis
78. Coexisting thyroid and gastric autoimmune disease are not due to cross‐reactive autoantibodies
79. New procedures for detecting Graves' immunoglobulins
80. Thyrotropin‐receptor blocking antibodies
81. Essential requirement for major histocompatibility complex recognition in T cell tolerance induction
82. Islet cell antibodies in juvenile diabetes mellitus of recent onset
83. Islet cell antibodies in juvenile diabetes mellitus
84. Epithelial HLA‐DR expression and T lymphocyte subsets in salivary glands in Sjorgren syndrome
85. Antibody to acetylcholine receptor in Myasthenia Gravis. Prevalence, clinical correlates and diagnostic value
86. Detection of HLA‐DR antigen in paraffin‐embedded thyroid epithelial cells with a monoclonal antibody
87. Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells
88. Analysis of intrathyroid T cells from a Hashimoto's thyroiditis gland
89. Epithelial cells expressing aberrant MHC Class II determinants can present antigen to cloned human T cells
90. Inhibition of parietal cell function by human gamma‐globulin containing gastric parietal cell antibodies
91. Autoantibodies to the insulin receptor in juvenile onset insuhn dependent diabetes
92. Gastric parietal cell antibodies: Demonstration by immunofluorescence of their reactivity with the surface of the gastric parietal cells
93. Viral particles induce la antigen expression on astrocytes
94. Familial neonatal transient hypothyroidism due to maternal TSH‐ binding inhibitor immunoglobulins
95. Expression of HLA‐ DR in hair follicles in alopecia areata
96. Humoral autoimmunity to gut‐related endocrine cells
97. Idiopathic protracted diarrhoea of infancy: an autoimmune variant
98. Activated T lymphocytes produce a matrix‐degrading heparan sulphate endoglycosidase
99. Antibodies to normal human melanocytes in vitiligo
100. Cytoplasmic’ islet cell antibodies: evidence that the target antigen is a sialoglycoprotein
101. Polyglandular autoimmune disease
102. Ultrastructure of intermediate stages in polarity reversal of thyroid epithelium in follicles in suspension culture
103. Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole
104. Insulin antibodies in insulin‐dependent diabetics before insulin treatment
105. Membrane antigens in thyroid autoimmune diseases
106. Autoantibodies are anti‐idiotype antibodies to antiviral antibodies
107. Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti‐ microsomal antibody
108. Parathyroid cell surface autoantibodies inhibit parathyroid hormone secretion from human parathyroid cells
109. Lymphocyte subpopulations and circulating immune complexes: their relationship in the pathogenesis of Type I (insulin‐dependent) diabetes
110. Lymphocytes capable of making monoclonal antibodies that react with multiple organs are a common feature of normal B cell repertoire
111. Lectin‐induced expression of DR antigen on human cultured follicular thyroid cells
112. Islet cell surface antibodies in Type I (insulin‐dependent) diabetes mellitus: use of human fetal pancreas cultures as substrate
113. In vivo and in vitro demonstration of HLA Class II products on human islet beta cells
114. Surface antigens of the human beta cells: detection of insulin and study of MHC modulation
115. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas
116. Antithyrotropin Antibodies in the Sera of Graves' Disease Patients
117. Prevailing theories in autoimmune disorders
118. Autoantibodies in Hashimoto's disease (lymphoadenoid goitre)
119. The cytoplasmic autoantigen of the human thyroid. I. Immunological and biochemical characteristics
120. Asialoagalactothyroglobulin binds to the surface of human thyroid cells at a site distinct from the ‘microsomal’ autoantigen
121. Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells (TEC) VII. Generation of thyroid specific cytotoxic effector cells
122. Human multiple organ‐reactive monoclonal autoantibody recognises growth hormone and a 35,000–molecular weight protein
123. Human monoclonal autoantibodies that react with multiple endocrine organs
124. Spectrum 168 BOTTAZZO ET AL. and profiles of non‐organ‐specific autoantibodies in autoimmune diseases
125. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant
126. Immunocytochemistry in the study and diagnosis of organ‐specific autoimmune diseases
127. Expression of HLA‐DR antigens by colonic epithelium in inflammatory bowel disease
128. Mouse antibodies to the insulin receptor developing spontaneously as anti‐idiotypes. I. Characterization of the antibodies
129. Autoantibodies to insulin receptor spontaneously develop as anti‐idiotypes in mice immunized with insulin
130. Antiinsulin receptor antibodies in an insulin‐dependent diabetic may arise as autoantiidiotypes
131. Recurrent diabetes mellitus in the pancreas iso and allograft: a light and electron microscopic and immunohistochemical analysis
132. Thyroid growth‐stimulating immunoglobulins in goitrous disease
133. Autoimmunity to insulin, beta cell dysfunction and development of insulin‐dependent diabetes mellitus
134. Effect of cyclosporine immunosuppression in insulin‐dependent diabetes mellitus of recent onset
135. Clinical and experimental islet and pancreas transplantation: overview of selected topic
136. Twin to twin pancreas transplantations: Reversal and re‐enactment of the pathogenesis of type I diabetes
137. A human mitochondrial antibody (AHMA). Its importance in the identification of organ‐specific reactions
138. Ramily studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer
139. Ramilial Cushing's syndrome due to nodular adrenocortical displasia, a putative receptor‐antibody disease
140. Dissection and characterization of the spontaneous and induced expression of HLA‐ D/DR by thyroid epithelium
141. Laboratory investigation of autoimmune endocrine diseases
142. HLA‐D subregion expression by thyrocytes is associated with the occurrence of circulating thyroid autoantibodies
143. TSH enhances expression by thyrocytes of interferon‐gamma induced HLA‐D/DR
144. Autoantigen presentation by target cells: its possible role in determining autoantibody specificity
145. Interferon‐gamma induces HLA‐DR expression by thyroid epithelium
146. Evidence for cell‐mediated immunity and specific suppressor T‐lymphocyte dysfunction in Graves' disease and diabetes mellitus
147. Antigen presentation: comments on its regulation and mechanism
148. Correlation of the HLA‐ Al B8 haplotypes with circulating autoantibodies in a family with increased incidence of autoimmune disease
149. Autoantibodies to gastrin‐producing cells in antral (Type B) chronic gastritis
150. Role of maternal immunoglobulin blocking TSH‐induced thyroid growth in sporadic forms of congenital hypothyroidism
151. Further studies on thyroid growth‐stimulating immunoglobulins in euthyroid nonendemic goiter
152. Antigen specific suppressor cell function in autoimmune chronic active hepatitis
153. Murine gamma interferon activates the release of a macrophage‐derived la‐inducing factor that transfers Ia inductive capacity
154. Epidermal growth factor modulates thyroid growth and function in culture
155. Value of insulin autoantibodies as serum markers for insulin‐dependent diabetes mellitus
156. Antibodies against human insulin
157. Immunoglobulins stimulating and blocking adrenal growth